Related Experiment Video
Updated: Nov 12, 2025
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Insights
Bronchopulmonary dysplasia (BPD) in preterm infants leads to significant developmental issues. While many treatments exist, only caffeine has proven effective in reducing BPD and improving long-term childhood development.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Developmental Pediatrics
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm infants, associated with severe neonatal respiratory complications.
- Infants requiring mechanical ventilation at 36 weeks post-menstrual age face increased risks of cerebral palsy, developmental delay, and cognitive deficits later in life.
- Despite advancements in neonatal care, BPD remains prevalent and linked to persistent poor developmental outcomes in children.
Purpose of the Study:
- To review the impact of bronchopulmonary dysplasia (BPD) on developmental outcomes in preterm infants.
- To evaluate the effectiveness of various therapeutic strategies for BPD and their influence on long-term development.
- To highlight the need for further research into developmental sequelae beyond school age and novel intervention strategies.
Main Methods:
- Literature review of studies on bronchopulmonary dysplasia (BPD) and its association with neurodevelopmental outcomes.
- Analysis of the impact of neonatal interventions, including mechanical ventilation and pharmacological therapies, on BPD.
- Synthesis of evidence regarding the efficacy of caffeine therapy in mitigating BPD and improving developmental trajectories.
Main Results:
- Mechanical ventilation at 36 weeks post-menstrual age is a significant predictor of adverse developmental outcomes, including cerebral palsy and cognitive impairment.
- While numerous therapies have been implemented, their impact on the long-term developmental sequelae of BPD is variable.
- Caffeine has demonstrated efficacy in reducing the incidence of BPD and improving developmental outcomes in childhood.
Conclusions:
- Bronchopulmonary dysplasia (BPD) poses a substantial risk for poor developmental trajectories throughout childhood and adolescence.
- Current therapeutic strategies have modulated BPD epidemiology but have not eliminated its association with developmental deficits.
- Future research must focus on understanding and addressing the long-term developmental consequences of BPD and rigorously evaluating new interventions before clinical adoption.
Abstract:
Preterm infants with bronchopulmonary dysplasia (BPD), and particularly those who develop the most severe forms of chronic lung disease during the neonatal period, are at high risk for poor developmental outcomes throughout childhood. Infants who require mechanical ventilation at 36 weeks post-menstrual age have significantly increased odds for cerebral palsy, developmental delay at 2 years, and poor academic achievement and low intelligence quotient in adolescence. Over the past several decades, many therapies and care strategies, including steroids, continuous positive airway pressure, surfactant, and other medications have been introduced into clinical practice. These approaches have changed the epidemiology of BPD in very preterm infants. However, BPD remains common and strongly associated with poor development throughout childhood. Only caffeine has been proven to reduce BPD and improve childhood developmental outcomes. In future research, it will be essential to better understand the developmental sequelae of BPD beyond school age and to test interventions to improve developmental trajectories in this population. As new management strategies for BPD are developed, it will be essential to rigorously evaluate both short-term and long-term effects before they are introduced into routine neonatal practice.
Related Concept Videos
01:17Pulmonary Cycle: Exhalation
01:05Breathing
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:30Pneumonia III: Complications and Assessment
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...